- Friday 1st of October 2021
Which conditions might lead a doctor Malegra 25 mg ?
Malegra 25 mg contains sildenafil citrate, a medicine used to treat erectile dysfunction (ED). A doctor may prescribe the 25 mg dose in several specific conditions where a lower strength is safer or more appropriate. Conditions or situations where a doctor might prescribe Malegra 25 mg Mild erectile dysfunction When symptoms are not severe, doctors may start with a low dose to see how well the patient responds. Older age (usually over 65 years) Older adults often Malegra 25 mg medicines more slowly, so a lower dose reduces the risk of side effects. Liver or kidney impairment Reduced organ function slows the breakdown of sildenafil, making lower doses safer. Use of interacting medications A doctor may choose 25 mg if the patient is taking medicines such as: Alpha-blockers for blood pressure or prostate issues Certain antifungals or antibiotics HIV medications These can increase sildenafil levels in the body. History of sensitivity to higher doses If a patient experiences strong side effects (headache, flushing, dizziness, vision changes) at higher doses, the 25 mg option may be recommended. Cardiovascular concerns Patients with controlled heart conditions may be started on a lower dose to reduce the strain on the heart. General precaution in first-time users Some doctors prefer to begin with a small dose to observe tolerance before adjusting upward. If you're unsure whether Malegra 25 mg is the right strength, it’s best to consult a healthcare professional who can evaluate your symptoms, health conditions, and medication profile.
Latest News
- Friday 1st of October 2021
“BIZ 2021” Entrepreneurial Day competition
- Friday 1st of October 2021
Workshop on modern assessment and the Use of Zoom Software in Learner-Centered Classroom (Academic staff)
- Friday 19th of March 2021
“Let’s Plant Trees for a Better Environment 2021”
- Friday 19th of March 2021
Biz 2020 – UWU Entrepreneurs’ Day
- Friday 19th of March 2021
Faculty of Management signs MoU with the Sri Lanka Institute of Marketing
- Friday 19th of March 2021
0 Replies:
Leave a Reply